CORC  > 复旦大学上海医学院
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
Wang, Chunyu; Fu, Xiaolong; Cai, Xuwei; Wu, Xianghua; Hu, Xichun; Fan, Min; Xiang, Jiaqing; Zhang, Yawei; Chen, Haiquan; Jiang, Guoliang
刊名ONCOTARGETS AND THERAPY
2016
卷号9
关键词esophageal squamous cell carcinoma epidermal growth factor receptor monoclonal antibody nimotuzumab
ISSN号1178-6930
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4287835
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Wang, Chunyu,Fu, Xiaolong,Cai, Xuwei,et al. High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy[J]. ONCOTARGETS AND THERAPY,2016,9.
APA Wang, Chunyu.,Fu, Xiaolong.,Cai, Xuwei.,Wu, Xianghua.,Hu, Xichun.,...&Zhao, Kuaile.(2016).High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy.ONCOTARGETS AND THERAPY,9.
MLA Wang, Chunyu,et al."High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy".ONCOTARGETS AND THERAPY 9(2016).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace